1 On page 1, in the affiliations footnote, "Klinik fur Her
2 On page 1, the institutional affiliation for Elvira Donn
3 See an invited perspective on this article
on page 1043.This multicenter phase II study investigate
4 A new study (see related article beginning
on page 1049) reveals a previously unrecognized associat
5 blood flow (see the related study beginning
on page 106).
6 d K. Vogel, and Edward Awh, which appeared
on pages 1128-1138 of the January 19, 2011 issue.
7 new study (see the related article beginning
on page 1142) reveals that it is not just the presence o
8 mphocytes (see the related article beginning
on page 1167).
9 On page 1203, in the first column, last paragraph, the s
10 On page 1204, in the second column, third complete parag
11 iferation (see the related article beginning
on page 1216).
12 e in mice (see the related article beginning
on page 1230).
13 new study (see the related article beginning
on page 1234) reports how TLR2 expression by endothelia
14 new study (see the related article beginning
on page 124) demonstrates that, after KSHV infection or
15 lood pressure (see related article beginning
on page 1244).
16 rculation (see the related article beginning
on page 1249).
17 settings (see the related articles beginning
on pages 1260 and 1270).
18 lated ECs (see the related article beginning
on page 1284).
19 sis of GN (see the related article beginning
on page 1286).
20 GGTase-I (see the related article beginning
on page 1294).
21 ibit HGP (see the related articles beginning
on pages 1306 and 1314).
22 se adults (see the related article beginning
on page 1322).
23 e aspects (see the related article beginning
on page 1354).
24 ne manner (see the related article beginning
on page 1360).
25 bilirubin (see the related article beginning
on page 137).
26 agonists (see the related article beginning
on page 1400).
27 mph nodes (see the related article beginning
on page 1405).
28 metformin (see the related article beginning
on page 1422).
29 ctivation (see the related article beginning
on page 1425).
30 acceptors (see the related article beginning
on page 1435).
31 l vectors (see the related article beginning
on page 1502).
32 receptors (see the related article beginning
on page 1514).
33 e animals (see the related article beginning
on page 1515).
34 ur et al. (see the related article beginning
on page 153) demonstrated that HSPGs under normal physio
35 stimulus (see the related article beginning
on page 1547).
36 mal HSCs (see the related articles beginning
on pages 1561 and 1581).
37 phenotype (see the related article beginning
on page 157).
38 lioration (see the related article beginning
on page 1595).
39 reuptake (see the related article beginning
on page 1595).
40 t in mice (see the related article beginning
on page 1616).
41 buminuria (see the related article beginning
on page 1645).
42 his issue (see the related article beginning
on page 165).
43 eutral pH (see the related article beginning
on page 1651).
44 infection (see the related article beginning
on page 1660).
45 phropathy (see the related article beginning
on page 1668).
46 n sensitivity (see related article beginning
on page 1686).
47 sor cells (see the related article beginning
on page 169).
48 uses FNDI (see the related article beginning
on page 1697).
49 entiation (see the related article beginning
on page 1707).
50 of Tregs (see the related article beginning
on page 1713).
51 a in rats (see the related article beginning
on page 1723).
52 nt, Stat1 (see the related article beginning
on page 1727).
53 halopathy (see the related article beginning
on page 173).
54 disease (see the related articles beginning
on pages 175, 185, and 195).
55 ial cells (see the related article beginning
on page 1756).
56 an others (see the related article beginning
on page 1762).
57 the JCI (see the related articles beginning
on pages 1796 and 1821) now report that obese adipose ti
58 ient mice (see the related article beginning
on page 1805).
59 opulation (see the related article beginning
on page 1806).
60 rrhythmia (see the related article beginning
on page 1814).
61 ease (PD) (see the related article beginning
on page 182).
62 rder zone (see the related article beginning
on page 1865).
63 s et al. (see the related articles beginning
on pages 1884 and 1893, respectively).
64 e the Editorial Commentary by Jehan and Qazi
on pages 190-1) BACKGROUND: Integrated Management of Chi
65 e the Editorial Commentary by Jehan and Qazi
on pages 190-1) Integrated Management of Childhood Illne
66 oimmunity (see the related article beginning
on page 2052).
67 estrained (see the related article beginning
on page 2062).
68 he heart (see the related articles beginning
on pages 2108, 2119, and 2128).
69 on cancer (see the related article beginning
on page 2111).
70 pregnancy (see the related article beginning
on page 2122).
71 fibrosis (see the related article beginning
on page 213).
72 throcytes (see the related article beginning
on page 2133).
73 diabetes (see the related article beginning
on page 2155).
74 + T cells (see the related article beginning
on page 2161).
75 nogenesis (see the related article beginning
on page 2171).
76 ein (APP) (see the related article beginning
on page 2190).
77 disorders (see the related article beginning
on page 2200).
78 therapy (see the related articles beginning
on pages 2225, 2233, and 2241).
79 aphylaxis (see the related article beginning
on page 2244).
80 variation (see the related article beginning
on page 225).
81 NOD mouse (see the related article beginning
on page 2252).
82 c hormone (see the related article beginning
on page 2260).
83 lammation (see the related article beginning
on page 2262).
84 r free Hb (see the related article beginning
on page 2271).
85 f the GBM (see the related article beginning
on page 2272).
86 ) T cells (see the related article beginning
on page 2279).
87 ent of HF (see the related article beginning
on page 229).
88 g obesity (see the related article beginning
on page 2291).
89 c neurons (see the related article beginning
on page 2325).
90 secretion (see the related article beginning
on page 2347).
91 ormations (see the related article beginning
on page 2356).
92 phenotype (see the related article beginning
on page 2366).
93 protein (see the related articles beginning
on pages 2385 and 2393).
94 imulation (see the related article beginning
on page 2456).
95 ble HDACs (see the related article beginning
on page 2459).
96 f the JCI (see the related article beginning
on page 246).
97 elucidated (see the related study beginning
on page 2468).
98 reported (see the related article beginning
on page 2500).
99 munocytes (see the related article beginning
on page 2517).
100 n in mice (see the related article beginning
on page 2526).
101 lase (sGC; see the related article beginning
on page 2552).
102 c setting (see the related article beginning
on page 2553).
103 f the JCI (see the related article beginning
on page 2574), have identified irritants that activate t
104 regulated (see the related article beginning
on page 258).
105 al weight (see the related article beginning
on page 2583).
106 gefitinib (see the related article beginning
on page 2609).
107 c therapy (see the related article beginning
on page 2610).
108 intestine (see the related article beginning
on page 2613).
109 ine VSMCs (see the related article beginning
on page 2634).
110 for eIF4E (see the related article beginning
on page 2638).
111 junctions (see the related article beginning
on page 266).
112 on (EMT) (see the related articles beginning
on pages 2663 and 2678, respectively).
113 e latter) (see the related article beginning
on page 2682).
114 nd memory (see the related article beginning
on page 272).
115 lization (see the related articles beginning
on pages 2745 and 2737, respectively).
116 emphysema in mice (see the related beginning
on page 2771).
117 n of MSCs (see the related article beginning
on page 2777).
118 ocarditis (see the related article beginning
on page 2799).
119 ter birth (see the related article beginning
on page 2808).
120 adipocyte (see the related article beginning
on page 2808).
121 ctivation (see the related article beginning
on page 2817).
122 ecipients (see the related article beginning
on page 2845).
123 ith MPS I (see the related article beginning
on page 2868).
124 n program (see the related article beginning
on page 2898).
125 In the companion article
on pages 3010-3021, we analyze how the measured kinetics
126 outcomes (see the related article beginning
on page 3026).
127 an AD-HSP (see the related article beginning
on page 3026).
128 in VSMCs (see the related article beginning
on page 303).
129 or (AT1R) (see the related article beginning
on page 3045).
130 use liver (see the related article beginning
on page 305).
131 systems (see the related articles beginning
on pages 3051 and 3065, respectively).
132 del of AD (see the related article beginning
on page 3060).
133 ne system (see the related article beginning
on page 3070).
134 er injury (see the related article beginning
on page 3072).
135 s reduced (see the related article beginning
on page 3102).
136 This "smart cell patch", described
on page 3115, effectively regulates the blood glucose le
137 c hypoxia (see the related article beginning
on page 3128).
138 d embryos (see the related article beginning
on page 3160).
139 e for fat (see the related article beginning
on page 3177).
140 mechanism (see the related article beginning
on page 3188).
141 h factors (see the related article beginning
on page 3198).
142 On page 320, R. R. Lunt and co-workers demonstrate elect
143 use model (see the related article beginning
on page 3204).
144 agulation (see the related article beginning
on page 3208).
145 a facile roll-to-plate process, as described
on page 3209.
146 te number (see the related article beginning
on page 3220).
147 d healing (see the related article beginning
on page 3277).
148 syndrome (see the related article beginning
on page 3291).
149 scribed by Q.-D. Shen, Z. Gu, and co-workers
on page 3313.
150 response (see the related article beginning
on page 3330).
151 ngiocytes (see the related article beginning
on page 3331).
152 nfections (see the related article beginning
on page 3339).
153 r disease (see the related article beginning
on page 3384).
154 nt of T1D (see the related article beginning
on page 3390).
155 human MS (see the related article beginning
on page 3403).
156 to HNSCC (see the related article beginning
on page 3408).
157 nal cells (see the related article beginning
on page 3437).
158 ptor PAR2 (see the related article beginning
on page 3453).
159 egulation (see the related article beginning
on page 3462).
160 structure (see the related article beginning
on page 353).
161 inal cord (see the related article beginning
on page 3530).
162 On page 3549, V. V. Tsukruk and co-workers develop self-
163 epitopes (see the related article beginning
on page 3563).
164 As described
on page 3564, the sequential patterning approach enables
165 studies (see the related articles beginning
on pages 357 and 370) use lamin A/C-deficient mice, whic
166 response (see the related article beginning
on page 3576).
167 in humans (see the related article beginning
on page 3583).
168 is added (see the related article beginning
on page 3651).
169 (See the Editorial Commentary by Martin
on pages 368-9.)Using population-based surveillance data
170 n in vivo (see the related article beginning
on page 3684).
171 potential (see the related article beginning
on page 369).
172 A (miRNA) (see the related article beginning
on page 3714).
173 rix is presented by C. Majidi and co-workers
on page 3726.
174 ents them (see the related article beginning
on page 3753).
175 llografts (see the related article beginning
on page 3774).
176 arcinomas (see the related article beginning
on page 3846).
177 n B cells (see the related article beginning
on page 3857).
178 in (TSLP) (see the related article beginning
on page 3868).
179 pogenesis (see the related article beginning
on page 387).
180 in vitro (see the related article beginning
on page 3917).
181 orylation (see the related article beginning
on page 3930).
182 esorption (see the related article beginning
on page 3954).
183 t in part (see the related article beginning
on page 3966).
184 tem cells (see the related article beginning
on page 3988).
185 nd death (see the related articles beginning
on pages 40 and 29, respectively).
186 duration (see the related article beginning
on page 4022).
187 r balance (see the related article beginning
on page 4025).
188 X. Zhao and co-workers develop
on page 4035 a new biocompatible hydrogel system that is
189 structure (see the related article beginning
on page 4044).
190 reports (see the related articles beginning
on pages 415 and 440) reveals that intrinsic T cell reac
191 tagenesis (see the related article beginning
on page 434) defined a new disorder of branched-chain am
192 sing, devices, and applications is discussed
on page 4397 by A. Javey and co-workers.
193 nted by H.-K. Baik, U. Jeong, and co-workers
on page 4455.
194 m is reported by J. A. Rogers and co-workers
on page 4462.
195 e pathway (see the related article beginning
on page 448).
196 IFN-gamma (see the related article beginning
on page 451).
197 On page 4684, C. Dames, L. Hu and co-workers report high
198 infection (see the related article beginning
on page 473).
199 MT events (see the related article beginning
on page 482).
200 As described
on page 4871, in each bundle, small gaps are formed betw
201 formation (see the related article beginning
on page 491).
202 direction (see the related article beginning
on page 492).
203 On page 4998, S. Yin, R. H. Baughman, and co-workers dem
204 As described
on page 5088, this reversible adhesive allows miniature
205 use model (see the related article beginning
on page 526).
206 s setting (see the related article beginning
on page 560).
207 Fornasiero and co-workers, as described
on page 5871, for application as a key component of prot
208 On page 5939, J. V. Badding and co-workers describe the
209 On page 6207, Y. Zhang, Z. Liu and co-workers describe m
210 cussed by X. Li, L. Colombo, and R. S. Ruoff
on page 6247.
211 of p-tau (see the related article beginning
on page 648).
212 ls to OME (see the related article beginning
on page 651).
213 aging ROS (see the related article beginning
on page 659).
214 ogenitors (see the related article beginning
on page 663).
215 On Page 6705, C. George, M. De Volder, and co-workers de
216 myocytes (see the related article beginning
on page 675).
217 ic states (see the related article beginning
on page 683).
218 h another part of the Codex, a complex table
on pages 69--74, reveals a concern on the part of the an
219 new paper (see the related article beginning
on page 701) demonstrates that LCs utilize these markers
220 oantigens (see the related article beginning
on page 712), some of which are associated with autoimmu
221 ly normal (see the related article beginning
on page 743).
222 me of HDL (see the related article beginning
on page 746).
223 lammation (see the related article beginning
on page 757).
224 entations (see the related article beginning
on page 765).
225 l nephron (see the related article beginning
on page 773).
226 a in mice (see the related article beginning
on page 79).
227 n in mice (see the related article beginning
on page 837).
228 rtension (see the related articles beginning
on pages 868 and 879, respectively).
229 acquisita (see the related article beginning
on page 870).
230 nhibitors (see the related article beginning
on page 876).
231 diseases (see the related article beginning
on page 888).
232 perfusion (see the related article beginning
on page 910).
233 ignaling (see the related articles beginning
on pages 93 and 103, respectively).
234 in humans (see the related article beginning
on page 936).
235 mal cells (see the related article beginning
on page 940).
236 and G-CSF (see the related article beginning
on page 946).
237 erentiate (see the related article beginning
on page 953).
238 the liver (see the related article beginning
on page 956).
239 new study (see the related article beginning
on page 96) shows that blocking the effect of GH in the
240 arthritis (see the related article beginning
on page 961).
241 pulations (see the related article beginning
on page 974).
242 in sepsis (see the related article beginning
on page 984).
243 nsmission (see the related article beginning
on page 99).